Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Minerva Surgical, Inc.
The purpose is to determine the safety and feasibility of using an intrauterine tissue resection system in the office setting, as well as to expand the national discussion regarding in-office hysteroscopic procedures as it relates to the highest standards of care and cost containment.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Subjects must meet the approved Instructions for Use for the Symphion® bipolar hysteroscopic tissue resection system
Confirmation hysteroscopic evaluation to access appropriate pathology type and size meets the Protocol guidelines for inclusion
Subject has signed written Informed Consent
You may not be if
Subjects who are pregnant
Subjects who have an active genital tract infection (as assessed by the physician)
Subjects who have cervical malignancies
Subjects who have previously been diagnosed with endometrial cancer
Subjects who have Type 2 intracavitary myomas
Type 0 or 1 intracavitary myoma greater than 3.0 cm
